The Establishment of CDK9/RNA PolII/H3K4me3/DNA Methylation Feedback Promotes HOTAIR Expression by RNA Elongation Enhancement in Cancer
Overview
Pharmacology
Authors
Affiliations
Long non-coding RNA HOX Transcript Antisense RNA (HOTAIR) is overexpressed in multiple cancers with diverse genetic profiles. Importantly, since HOTAIR heavily contributes to cancer progression by promoting tumor growth and metastasis, HOTAIR becomes a potential target for cancer therapy. However, the underlying mechanism leading to HOTAIR deregulation is largely unexplored. Here, we performed a pan-cancer analysis using more than 4,200 samples and found that intragenic exon CpG island (Ex-CGI) was hypermethylated and was positively correlated to HOTAIR expression. Also, we revealed that Ex-CGI methylation promotes HOTAIR expression through enhancing the transcription elongation process. Furthermore, we linked up the aberrant intragenic tri-methylation on H3 at lysine 4 (H3K4me3) and Ex-CGI DNA methylation in promoting transcription elongation of HOTAIR. Targeting the oncogenic CDK7-CDK9-H3K4me3 axis downregulated HOTAIR expression and inhibited cell growth in many cancers. To our knowledge, this is the first time that a positive feedback loop that involved CDK9-mediated phosphorylation of RNA Polymerase II Serine 2 (RNA PolII Ser2), H3K4me3, and intragenic DNA methylation, which induced robust transcriptional elongation and heavily contributed to the upregulation of oncogenic lncRNA in cancer has been demonstrated. Targeting the oncogenic CDK7-CDK9-H3K4me3 axis could be a novel therapy in many cancers through inhibiting the HOTAIR expression.
ONeill K, Pleasance E, Fan J, Akbari V, Chang G, Dixon K Cell Genom. 2024; 4(11):100674.
PMID: 39406235 PMC: 11605692. DOI: 10.1016/j.xgen.2024.100674.
Tan Y, Qiao J, Yang S, Liu H, Wang Q, Liu Q Adv Sci (Weinh). 2024; 11(24):e2309140.
PMID: 38639399 PMC: 11199983. DOI: 10.1002/advs.202309140.
A concise review of the regulatory, diagnostic, and prognostic implications of HOXB-AS3 in tumors.
Wu H, Ye J, Zhang M, Luo H J Cancer. 2024; 15(3):714-728.
PMID: 38213732 PMC: 10777036. DOI: 10.7150/jca.91033.
Yin J, Ding N, Yu J, Wang Z, Fu L, Li Y Mol Ther Nucleic Acids. 2023; 34:102058.
PMID: 38028194 PMC: 10630662. DOI: 10.1016/j.omtn.2023.102058.
Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma.
Wang J, Wong C, Zhu Y, Yao X, Ng K, Zhou C Biomark Res. 2023; 11(1):74.
PMID: 37553583 PMC: 10410818. DOI: 10.1186/s40364-023-00514-4.